Co-Authors
This is a "connection" page, showing publications co-authored by Chia Kow and Hamid Merchant.
Connection Strength
1.617
-
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials. Expert Rev Respir Med. 2021 08; 15(8):1049-1055.
Score: 0.239
-
Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK. J Infect. 2021 07; 83(1):e14-e15.
Score: 0.236
-
The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021 Oct; 73(5):1473-1479.
Score: 0.234
-
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021 08; 15(8):973-978.
Score: 0.233
-
Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590.
Score: 0.226
-
Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020 Aug - Sep; 170:106045.
Score: 0.221
-
Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021 Jun; 29(1):217-221.
Score: 0.058
-
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
Score: 0.057
-
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 11; 14(11):1149-1163.
Score: 0.057
-
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? Int J Infect Dis. 2020 Dec; 101:107-120.
Score: 0.057